Volume 31, Issue 43
Heterocyclic Compounds
Full Access

ChemInform Abstract: Synthesis and Serotonin 2 (5-HT2) Receptor Antagonist Activity of 5-Aminoalkyl-Substituted Pyrrolo[3,2-c]azepines and Related Compounds.

Akira Mizuno

Akira Mizuno

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
Atsuto Ogata

Atsuto Ogata

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
Tomoe Kamei

Tomoe Kamei

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
Makoto Shibata

Makoto Shibata

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
Tetsuo Shimamoto

Tetsuo Shimamoto

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
Yasuhiro Hayashi

Yasuhiro Hayashi

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
Kyoko Nakanishi

Kyoko Nakanishi

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
Chikako Takiguchi

Chikako Takiguchi

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
Naomi Oka

Naomi Oka

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
Norio Inomata

Norio Inomata

Suntory Inst. Bioorg. Res., Shimamoto, Osaka 618, Japan

Search for more papers by this author
First published: 01 June 2010

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

ChemInform Abstract

Ongoing studies lead to the synthesis of a novel series of compounds such as (VI) via different approaches. The most interesting substance is the (S)-enantiomer of (VIa), named SUN C5174, obtained from the racemate via diastereomeric salt formation with L-(+)-tartaric acid followed by fractional recrystallization. The (S)-configuration is established by X-ray analysis of the corresponding salt. SUN C5174 is chosen for clinical trials for the treatment of peripheral circulatory diseases. The preparation of the starting materials (I) is described.

chemical structure image

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.